All Stories

  1. Protective effect of probiotic and prebiotic fermented milk containing Lactobacillus fermentum against obesity‐induced hepatic steatosis and inflammation
  2. Dietary intake of probiotic fermented milk benefits the gut and reproductive health in mice fed with an obesogenic diet
  3. Proteomics analysis of MSN, MWCNT and ZnO nanoparticle-induced alteration in prepubertal rat ovary
  4. Novel and known miRNAs in zebu (Tharparkar) and crossbred (Karan-Fries) cattle under heat stress
  5. MSN, MWCNT and ZnO nanoparticle-induced CHO-K1 cell polarisation is linked to cytoskeleton ablation
  6. Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents
  7. Erratum: Synthesis of novel 4,5‐dihydropyrrolo[1,2‐ a ]quinoxalines, pyrrolo[1,2‐ a ]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity
  8. Synthesis of novel 4,5‐dihydropyrrolo[1,2‐ a ]quinoxalines, pyrrolo[1,2‐ a ]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity
  9. Comparative toxicity assessment of nano- and bulk-phase titanium dioxide particles on the human mammary gland in vitro
  10. Synthesis and Biological Studies of Dodecameric Cationic Antimicrobial Peptides Containing Tetrahydrofuran Amino Acids
  11. Postnatal distribution of ZnO nanoparticles to the breast milk through oral route and their risk assessment for breastfed rat offsprings
  12. Vancomycin Derivative Inactivates Carbapenem-Resistant Acinetobacter baumannii and Induces Autophagy
  13. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis
  14. New fluoroquinolone compounds with endo ‐nortropine derivatives at C‐7 position show antibacterial activity against fluoroquinolone‐resistant strains of Staphylococcus aureus
  15. Update on drug-repurposing: is it useful for tackling antimicrobial resistance?
  16. Repurposing disulfiram for treatment of Staphylococcus aureus infections
  17. Exploration of immunomodulatory and protective effect of Withania somnifera on trace metal oxide (zinc oxide nanoparticles) induced toxicity in Balb/c mice
  18. Synthesis and evaluation of new 4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant Staphylococcus aureus
  19. Nucleobase Soft Metallogel Composites with Antifouling Activities against ESKAPE Pathogens
  20. Targeted Antibacterial Activity Guided by Bacteria-Specific Nitroreductase Catalytic Activation to Produce Ciprofloxacin
  21. A novel molecular scaffold resensitizes multidrug-resistant S. aureus to fluoroquinolones
  22. Management of multidrug-resistant tuberculosis in the 21st century
  23. Rationally designed curcumin based ruthenium(ii) antimicrobials effective against drug-resistant Staphylococcus aureus
  24. Sarecycline hydrochloride for the treatment of acne vulgaris
  25. Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)
  26. Machine Learning in High Energy Physics Community White Paper
  27. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus
  28. Comparative evaluation of half-maximum inhibitory concentration and cytotoxicity of silver nanoparticles and multiwalled carbon nanotubes using buffalo bull spermatozoa as a cell model
  29. Mesoporous silica nanoparticle is comparatively safer than zinc oxide nanoparticle which can cause profound steroidogenic effects on pregnant mice and male offspring exposed in utero
  30. Enhanced steroidogenic and altered antioxidant response by ZnO nanoparticles in mouse testis Leydig cells
  31. Gepotidacin. Broad-spectrum DNA topoisomerase II inhibitor, Treatment of bacterial infections
  32. Delafloxacin meglumine for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
  33. Delpazolid. Oxazolidinone antibiotic, Treatment of tuberculosis
  34. Comparative in vivo toxicity assessment places multiwalled carbon nanotubes at a higher level than mesoporous silica nanoparticles
  35. A High Performance Storage Appliance for Genomic Data
  36. Cereulide and diarrheal toxin contamination in milk and milk products: a systematic review
  37. Nonviral gene transfer to human meniscal cells. Part I: transfection analyses and cell transplantation to meniscus explants
  38. Rapid method for measuring the mechanical properties of pharmaceutical compacts
  39. Ultrasonic real-time in-die monitoring of the tablet compaction process—A proof of concept study
  40. Determining API domain sizes in pharmaceutical tablets and blends upon varying milling conditions by near-infrared chemical imaging
  41. Water Enhancement of CO2Conversion on Silver in 1-Ethyl-3-Methylimidazolium Tetrafluoroborate
  42. Temporal and spatial migration pattern of the subchondral bone plate in a rabbit osteochondral defect model
  43. Health hazards associated with nanomaterials
  44. Failed cartilage repair for early osteoarthritis defects: a biochemical, histological and immunohistochemical analysis of the repair tissue after treatment with marrow-stimulation techniques
  45. In-die ultrasonic and off-line air-coupled monitoring and characterization techniques for drug tablets
  46. Quality-by-Design Case Study: Investigation of the Role of Poloxamer in Immediate-Release Tablets by Experimental Design and Multivariate Data Analysis
  47. Transplanted articular chondrocytes co-overexpressing IGF-I and FGF-2 stimulate cartilage repair in vivo
  48. A PAT Approach to Improve Process Understanding of High Shear Wet Granulation Through In-Line Particle Measurement Using FBRM C35
  49. Acceleration of articular cartilage repair by combined gene transfer of human insulin-like growth factor I and fibroblast growth factor-2 in vivo
  50. A Cost-Utility Analysis of Amputation versus Salvage for Gustilo Type IIIB and IIIC Open Tibial Fractures
  51. Quality by design case study: An integrated multivariate approach to drug product and process development
  52. Symposium on “Food Technology for Better Nutrition”
  53. Analysis of Novel Nonviral Gene Transfer Systems for Gene Delivery to Cells of the Musculoskeletal System
  54. Effect of transforming growth factor-beta 1 (TGF-ß1) released from a scaffold on chondrogenesis in an osteochondral defect model in the rabbit
  55. Tumor-Targeted Gene Delivery Using Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles: In Vitro and in Vivo Studies
  56. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I)
  57. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2)in vivo
  58. Cellular Interactions and In Vitro DNA Transfection Studies with Poly(ethylene glycol)‐Modified Gelatin Nanoparticles
  59. Biodistribution and Targeting Potential of Poly(ethylene glycol)-modified Gelatin Nanoparticles in Subcutaneous Murine Tumor Model
  60. Menisci are Efficiently Transduced by Recombinant Adeno-Associated virus Vectors in Vitro and in Vivo
  61. Value versus Glamour
  62. An Anatomy of Trading Strategies
  63. Profitability of Short-Term Contrarian Strategies: Implications for Market Efficiency
  64. Oil and the Stock Markets
  65. 9 Predictable components in stock returns
  66. Trading Volume and Transaction Costs in Specialist Markets
  67. Information, trading, and volatility
  68. Long-Term Market Overreaction or Biases in Computed Returns?
  69. Local particle densities and global multiplicities in central heavy ion interactions at 3.7, 14.6, 60 and 200A GeV
  70. On intermittency in heavy-ion collisions and the importance of γ-conversion in a multi-dimensional intermittency analysis
  71. Rapidity density distributions inO16,Si28,S32,Au197, andPb208induced heavy-ion interactions at 4A–200AGeV
  72. Review of recent results on particle production from EMU01
  73. A systematic study of the energy independent behaviour of the fragmentation regions in16O-Em interactions from 3.7 to 200A GeV
  74. Components of short-horizon individual security returns
  75. Multiplicities ininduced16violent heavy-ion collisions from 5Ato 2×105AMeV
  76. Energy, target, projectile and multiplicity dependences of intermittency behaviour in high energy O(Si, S) induced interactions
  77. On the systematic behaviour of the intermittency-indices in nuclear interactions
  78. Slow, target associated particles produced in ultrarelativistic heavy-ion interactions
  79. Photon-induced emission of pions and protons from various nuclei in the Δ-resonance region
  80. Price reversals
  81. Monetary Regimes and the Relation Between Stock Returns and Inflationary Expectations
  82. Scaled-factorial-moment analysis of 200A-GeV sulfur+gold interactions
  83. On the multiplicity fluctuations in relativistic heavy ion collisions
  84. Relative Price Variability, Real Shocks, and the Stock Market
  85. Dimuon production by neutrinos in the Fermilab 15-ft bubble chamber at the Tevatron
  86. Limiting Fragmentation, Scaling and Substructual Dependence of Multiparticle Production in High Energy Heavy Ion Reactions
  87. Target nucleus fragmentation in 16O+(Ag,Br) interactions at 200 A GeV
  88. Coherent production of π^{+} and π^{-} mesons by charged-current interactions of neutrinos and antineutrinos on neon nuclei at the Fermilab Tevatron
  89. A study of recoil protons in ultra-relativistic nucleus-nucleus collisions
  90. Rapidity densities and their fluctuations in central 200 A GeV 32S interactions with Au and Ag, Br nuclei EMU01 collaboration
  91. Limiting fragmentation in oxygen-induced emulsion interactions at 14.6, 60, and 200 GeV/nucleon
  92. Scaling properties of charged particle multiplicity distributions in oxygen induced emulsion interactions at 14.6, 60 and 200 A GeV
  93. Search for anomalous interaction mean free paths of charge, 2?Z?18 projectile fragments in emulsions exposed to 1.8 A GeV40Ar ions
  94. Stock returns and inflation
  95. A study of $$\bar np$$ annihilations between 0.5 and 0.8 GeV/c
  96. Charged charm production in proton-emulsion interactions at 400 GeV/c
  97. Studies of $$\bar pp \to \bar nn$$ and $$\bar np$$ annihilation at incident momenta of 700 and 760 MeV/c
  98. Polarization ofΛ 0 hyperons inK − p interactions
  99. Search for anomalous fragments in 1.8A-GeVAr
  100. Neutral charm production in 400 GeV proton-emulsion interactions
  101. Feeding Behaviour and Digestion Pattern in Stylonychia mytilusEhrenberg
  102. Some observations on the systematics in high-energy p-Nucleus interactions
  103. Charm production in 400 GeV/c proton-emulsion interactions
  104. Relativistic α-particles emitted in Fe-emulsion interactions at 1.7A GeV
  105. Target mass dependence of charged particle multiplicity inp-nucleus interactions
  106. Four-momentum transfer between groups of secondary particles in proton-nucleus interactions at 200 GeV
  107. Variation of average charged particle multiplicity inp-nucleus interactions with energy and the two component description of particle production at high energies
  108. Inelastic interactions of 9.38 GeV/c deuteron in emulsion
  109. Study of Elastic (π-p) and Coherent (π-C) Cross-Section at 40 GeV/c Using Propane (C3H8) Bubble Chamber
  110. Charged particle multiplicity in 400 GeV/c p-nucleus interactions in nuclear emulsion
  111. Energy dependence of multiplicity in proton-nucleus collisions and models of multiparticle production
  112. Temperature variable system with low helium consumption
  113. Multiplicity in proton-nucleus interactions at 200 GeV/c
  114. MESENTERIC VASCULAR OCCLUSION